mRNA Vaccine Insights

Josh and Chuck discuss the unique characteristics of mRNA vaccines, emphasizing the speed of development due to ample funding and large sample sizes. They delve into the emergency use authorization process, highlighting the safety measures taken by the FDA without cutting corners.